P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA

• Danielle H. Oh,
• Xiao MA,
• Jackson He,
• Conor Kearney,
• Simon J. Hogg,
• Andrea Newbold,
• Peter Fraser,
• Ian G. Jennings,
• Daniella Brasacchio,
• Olivia Susanto,
• Chun Yew Fong,
• Mark A. Dawson,
• Emily Gruber,
• Lev Kats,
• Ricky W. Johnstone,
• Philip E. Thompson,
• Jake Shortt

Affiliations

Danielle H. Oh

1 Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Xiao MA

5 Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

Jackson He

1 Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Conor Kearney

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Simon J. Hogg

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Andrea Newbold

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Peter Fraser

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Ian G. Jennings

5 Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

Daniella Brasacchio

1 Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Olivia Susanto

1 Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Chun Yew Fong

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Mark A. Dawson

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Emily Gruber

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Lev Kats

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Ricky W. Johnstone

3 Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Philip E. Thompson

5 Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

Jake Shortt

1 Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia